rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

524816 NATCOPHARM Group (B)

Natco Pharma Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
1523.00   30.10   2.02%
Volume 4,045
Prev close 1,492.90
Day's H/L (Rs.) 1,539.00 - 1,499.80
52wk H/L (Rs.) 1,585.70 - 605.10
Mkt Cap (Rs. Cr) 5,117.28
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

NATCOPHARM

Natco Pharma Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
1524.50   33.55   2.25%
Volume 131,641
Prev close 1490.95
Day's H/L (Rs.) 1,539.90 - 1,495.05
52wk H/L (Rs.) 1,590.00 - 602.40
Turnover (Rs. Lacs) 2,004.41
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Market Voices for Natco Pharma Ltd.  (See all 141 market voices)   

140 Characters
  Cancel
Expert Voices - 08 Sep 2014
#Natco-Pharma-Ltd
files ANDA for Everolimus, 0.25 mg, 0.5 mg and 0.75 mg tablets. (NDTV Profit)
Reply   |   Share
Sree kanth - 1 week ago  This share target is Rs.2000/- on or before 31st Oct, 2014 after that it will spilt this share.
Reply   |  Share
Sarfaraz Hussain - 2 day(s) ago Dear Traders/Investers do not go with rumours trade with only SEBI Registered investment adviser with proper risk & reward ratio for more information visit http://rediff.ly/37m87 and register
#Natco-Pharma-Ltd
Reply   |   Share

Realtime news for Natco Pharma Ltd. (See all 279 news)

20 September 2014, 11:28
Natco Pharma Limited, Hit With A Strong Dose Of FDA Medicine - 17 hour(s) ago
Natco's Formulation Facility at Kothur found acceptable by USFDA - 1 day(s) ago
Natco Pharma stock surges 5% - 05 Sep 2014
Natco Pharma extends gain; stock up another 4.5% - 08 Sep 2014
NATCO Pharma Q1 net profit increases - 27 Aug 2014

BSE Announcements from Natco Pharma Ltd. (See all)

Natco's Kothur Formulation Facility found acceptable by USFDA - 2 day(s) ago
NATCOs marketing partner, Mylan Inc., files ANDA for Three Times Per Week Generic Copaxoney 40 mg/mL - 30 Aug 2014

Company details for Natco Pharma Ltd.

Report Card

PE Ratios
44.80
EPS (Rs.)
33.32
Sales (Rs. Cr)
181.48
Face Value (Rs.)
10
Net Profit
Margin (%)
 
17.27
Last Bonus
Last Dividend(%)
50
Return on
Average Equity
 
15.03

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Natco Pharma Ltd. performance snapshot

If you had invested Rs.  in Natco Pharma Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Natco Pharma Ltd. with other stocks

Piramal Enterprises Ltd.
783.25
Cadila Healthcare Ltd.
1,267.30
Show more companies
Piramal Enterprises Ltd.
783.25
Cadila Healthcare Ltd.
1,267.30
GlaxoSmithKline Pharmaceuticals Ltd.
2,505.50
Ipca Laboratories Ltd.
780.40
Apollo Hospitals Enterprise Ltd.
1,144.95
Aurobindo Pharma Ltd.
883.80
Biocon Ltd.
499.95
Cipla Ltd.
620.25
Divi's Laboratories Ltd.
1,735.35
Dr. Reddy's Laboratories Ltd.
3,187.75
Show less companies
Close
Add Natco Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Natco Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close